Celsis International is a leading provider of innovative life science products and laboratory services to the pharmaceutical and consumer products industries worldwide through its three business areas, featuring rapid microbial detection systems, analytical laboratory services and in vitro ADME-Tox products.
Each Celsis division delivers substantial time and cost savings to customers in addition to ensuring product quality and safety for consumers. Founded in Cambridge, England (UK), by Sir Christopher Evans, Celsis was floated on the London Stock Exchange (CEL.L) in1993. In October 2009, the company was acquired by a private equity company. As a result, the company is now private. Headquartered in Chicago with major facilities in the U.S. and Europe, Celsis employs 220 people worldwide.
Company News
Careers
Interested in joining the Celsis team? Learn more about current career opportunities and company benefits.
Quality
Celsis is committed to quality in our products, services and customer relationships. Learn more about our quality commitment and policies.
